Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

The analysis of the financial data over the reported periods reveals several key trends concerning the share price, operating profit per share, and the price-to-operating-profit (P/OP) ratio.

Share Price Dynamics

The share price exhibited a general upward trajectory from 2006 to 2024, despite some fluctuations. Initially, the price increased modestly from $16.37 in 2006 to $37.67 in 2011, followed by a significant surge reaching a peak of $936.33 in 2023. This marked rise indicates strong market confidence or growth prospects during this time. However, there was a notable decline in 2025 to $716.72, suggesting a potential correction or market revaluation after the peak.

Operating Profit Per Share Trends

Operating profit per share started negative in 2006 at -$2.19 and remained below zero until 2011, indicating losses during the company’s early years. Commencing in 2012, there was a sharp improvement with profits becoming positive and progressively increasing. The operating profit per share peaked at $82.43 in 2022, pointing to substantial profitability growth. However, there was a decline in the subsequent years to $36.87 in 2024 and $36.50 in 2025, reflecting some reduction in operational efficiency or profitability despite still maintaining a positive level.

Price to Operating Profit Ratio (P/OP)

Data for the P/OP ratio is available from 2014 onwards and demonstrates notable variability. The ratio initially was high at 35.11 in 2014 and remained elevated around 40 to 50 through 2016, suggesting that the market-priced the shares at a premium relative to operating profits. From 2017, the ratio exhibited a downward trend, reaching a low of 7.55 in 2022, implying that operating profits had increased substantially relative to share price, potentially indicating undervaluation or a rapid rise in profitability. After 2022, the ratio rose again to 25.39 and then slightly decreased to 19.63 by 2025, signaling fluctuations in market valuation relative to operating profit.

Overall, the data reveals that the company transitioned from operating losses to significant profitability over the observed period. The share price increased considerably in alignment with improving profitability, although some volatility and corrections occurred. The P/OP ratio trends highlight shifts in market perception of the company’s value relative to its operational performance.